|Last Quarterly Update:||10/28/2013|
|Industry Overview||Trends & Challenges||Industry Forecast|
|Quarterly Industry Update||Call Prep Questions||Website & Media Links|
|Business Challenges||Financial Information||Glossary & Acronyms|
Companies in this industry provide outpatient kidney dialysis services. Major companies include US-based DaVita and Dialysis Clinic, Inc., and Germany-based Fresenius Medical Care and B. Braun Melsungen.
The US commercial kidney dialysis industry includes about 4,200 centers with combined annual revenue of about $16 billion.
Demand depends on the number of people who suffer from kidney disease. The profitability of individual companies is linked to efficient operations and good marketing. Large companies have economies of scale in administrative costs, which has driven consolidation in the industry. The US industry is highly concentrated: the four largest companies operate more than 90 percent of all centers. Small operators can compete successfully if they have centers in desirable locations or good relations with doctors who refer patients.
More than 600,000 people in the US have end-stage renal disease, and about 415,000 of them receive treatment in dialysis centers. The number of people receiving dialysis grew at a compound annual rate of 4 percent between 2000 and 2010, according to the US Renal Data System.
PRODUCTS, OPERATIONS & TECHNOLOGY
The industry provides a treatment called hemodialysis for patients who suffer from end-stage renal disease (ESRD). Hemodialysis, the most common form of treatment for ESRD, is not a cure but a blood-filtering process that prolongs life. ESRD patients must undergo dialysis for the rest of their lives. Without dialysis treatment or a kidney transplant, ESRD is a terminal disease. Diabetes and high ...
Would you or your company benefit from having unlimited access to First Research's industry intelligence tools?Learn More About Subscription Options